VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q97093714 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235812.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q97093714‏
035 ‎‡a (OCoLC)Q97093714‏
100 0 ‎‡a Bo Wang‏ ‎‡c immunologist‏ ‎‡9 en‏
670 ‎‡a Author's A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells‏
670 ‎‡a Author's Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues‏
670 ‎‡a Author's Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration‏
670 ‎‡a Author's Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage‏
670 ‎‡a Author's beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct‏
670 ‎‡a Author's CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.‏
670 ‎‡a Author's Cutting edge: Antigen-specific thymocyte feedback regulates homeostatic thymic conventional dendritic cell maturation‏
670 ‎‡a Author's Dysregulation of Thymic Clonal Deletion and the Escape of Autoreactive T Cells‏
670 ‎‡a Author's Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice‏
670 ‎‡a Author's Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes‏
670 ‎‡a Author's IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells‏
670 ‎‡a Author's Immunotherapy of type 1 diabetes‏
670 ‎‡a Author's Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes‏
670 ‎‡a Author's Isolation and transplantation of different aged murine thymic grafts‏
670 ‎‡a Author's Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies‏
670 ‎‡a Author's MerTK is required for apoptotic cell-induced T cell tolerance‏
670 ‎‡a Author's MerTK regulates thymic selection of autoreactive T cells‏
670 ‎‡a Author's Parameters influencing antigen-specific immunotherapy for Type 1 diabetes‏
670 ‎‡a Author's Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity‏
670 ‎‡a Author's Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes‏
670 ‎‡a Author's Role of plasmacytoid dendritic cells in type 1 diabetes: friend or foe?‏
670 ‎‡a Author's Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination‏
670 ‎‡a Author's T-cell promiscuity in autoimmune diabetes‏
670 ‎‡a Author's Temporal increase in thymocyte negative selection parallels enhanced thymic SIRPα+ DC function‏
670 ‎‡a Author's Thymic Dendritic Cell Subsets Display Distinct Efficiencies and Mechanisms of Intercellular MHC Transfer‏
670 ‎‡a Author's Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner‏
670 ‎‡a Author's β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice‏
670 ‎‡a Author's β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice‏
919 ‎‡a parametersinfluencingantigenspecificimmunotherapyfortype1diabetes‏ ‎‡A Parameters influencing antigen-specific immunotherapy for Type 1 diabetes‏ ‎‡9 1‏
919 ‎‡a autoreactiveeffectormemorycd4+andcd8+tcellsinfiltratinggraftedandendogenousisletsindiabeticnodmiceexhibitsimilartcellreceptorusage‏ ‎‡A Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage‏ ‎‡9 1‏
919 ‎‡a antibodybindingtocd4inducesracgtpaseactivationandalterstcellmigration‏ ‎‡A Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration‏ ‎‡9 1‏
919 ‎‡a mertkregulatesthymicselectionofautoreactivetcells‏ ‎‡A MerTK regulates thymic selection of autoreactive T cells‏ ‎‡9 1‏
919 ‎‡a cd8+tcellsspecificforbetacellsencountertheircognateantigensintheisletsofnodmice‏ ‎‡A CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.‏ ‎‡9 1‏
919 ‎‡a reducedil2expressioninnodmiceleadstoatemporalincreaseincd62llofoxp3+cd4+tcellswithlimitedsuppressoractivity‏ ‎‡A Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity‏ ‎‡9 1‏
919 ‎‡a cuttingedgeantigenspecificthymocytefeedbackregulateshomeostaticthymicconventionaldendriticcellmaturation‏ ‎‡A Cutting edge: Antigen-specific thymocyte feedback regulates homeostatic thymic conventional dendritic cell maturation‏ ‎‡9 1‏
919 ‎‡a dysregulationofthymicclonaldeletionandtheescapeofautoreactivetcells‏ ‎‡A Dysregulation of Thymic Clonal Deletion and the Escape of Autoreactive T Cells‏ ‎‡9 1‏
919 ‎‡a βcellspecificil35therapysuppressesongoingautoimmunediabetesinnodmice‏ ‎‡A β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice‏ ‎‡9 1‏
919 ‎‡a βcellspecificil2therapyincreasesisletfoxp3+tregandsuppressestype1diabetesinnodmice‏ ‎‡A β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice‏ ‎‡9 1‏
919 ‎‡a reestablishingtcelltolerancebyantibodybasedtherapyintype1diabetes‏ ‎‡A Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes‏ ‎‡9 1‏
919 ‎‡a genegunmediateddnavaccinationenhancesantigenspecificimmunotherapyatalatepreclinicalstageoftype1diabetesinnonobesediabeticmice‏ ‎‡A Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice‏ ‎‡9 1‏
919 ‎‡a mertkisrequiredforapoptoticcellinducedtcelltolerance‏ ‎‡A MerTK is required for apoptotic cell-induced T cell tolerance‏ ‎‡9 1‏
919 ‎‡a roleofplasmacytoiddendriticcellsintype1diabetesfriendorfoe‏ ‎‡A Role of plasmacytoid dendritic cells in type 1 diabetes: friend or foe?‏ ‎‡9 1‏
919 ‎‡a longtermremissionofdiabetesinnodmiceisinducedbynondepletinganticd4andanticd8antibodies‏ ‎‡A Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies‏ ‎‡9 1‏
919 ‎‡a ifnγreceptordeficiencypreventsdiabetesinductionbydiabetogeniccd4+butnotcd8+tcells‏ ‎‡A IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells‏ ‎‡9 1‏
919 ‎‡a geneticvaccinationforreestablishingtcelltoleranceintype1diabetes‏ ‎‡A Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes‏ ‎‡9 1‏
919 ‎‡a suppressionofongoingtcellmediatedautoimmunitybypeptidemhcclass2dimervaccination‏ ‎‡A Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination‏ ‎‡9 1‏
919 ‎‡a thymicdevelopmentofautoreactivetcellsinnodmiceisregulatedinanagedependentmanner‏ ‎‡A Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner‏ ‎‡9 1‏
919 ‎‡a tcellpromiscuityinautoimmunediabetes‏ ‎‡A T-cell promiscuity in autoimmune diabetes‏ ‎‡9 1‏
919 ‎‡a temporalincreaseinthymocytenegativeselectionparallelsenhancedthymicsirpα+600function‏ ‎‡A Temporal increase in thymocyte negative selection parallels enhanced thymic SIRPα+ DC function‏ ‎‡9 1‏
919 ‎‡a isolationandtransplantationofdifferentagedmurinethymicgrafts‏ ‎‡A Isolation and transplantation of different aged murine thymic grafts‏ ‎‡9 1‏
919 ‎‡a thymicdendriticcellsubsetsdisplaydistinctefficienciesandmechanismsofintercellularmhctransfer‏ ‎‡A Thymic Dendritic Cell Subsets Display Distinct Efficiencies and Mechanisms of Intercellular MHC Transfer‏ ‎‡9 1‏
919 ‎‡a inducibleadenoassociatedvirusmediatedil2genetherapypreventsautoimmunediabetes‏ ‎‡A Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes‏ ‎‡9 1‏
919 ‎‡a novelrolefor100srcandstat3inapoptoticcellmediatedmertkdependentimmunoregulationofdendriticcells‏ ‎‡A A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells‏ ‎‡9 1‏
919 ‎‡a anticoreceptortherapydrivesselectivetcellegressbysuppressinginflammationdependentchemotacticcues‏ ‎‡A Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues‏ ‎‡9 1‏
919 ‎‡a immunotherapyoftype1diabetes‏ ‎‡A Immunotherapy of type 1 diabetes‏ ‎‡9 1‏
919 ‎‡a betacellspecificcd4+tcellclonotypesinperipheralbloodandthepancreaticisletsaredistinct‏ ‎‡A beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct‏ ‎‡9 1‏
996 ‎‡2 NTA|176922792
996 ‎‡2 DNB|1048461866
996 ‎‡2 ISNI|0000000505843063
996 ‎‡2 DNB|1295939894
996 ‎‡2 ISNI|0000000078926680
996 ‎‡2 LC|n 88219575
996 ‎‡2 DNB|1059796031
996 ‎‡2 ISNI|0000000081601027
996 ‎‡2 DNB|113698156X
996 ‎‡2 DNB|1315508079
996 ‎‡2 LC|no2003051476
996 ‎‡2 ISNI|0000000047478694
996 ‎‡2 LC|n 2019071539
996 ‎‡2 LC|no2014152136
996 ‎‡2 CYT|AC000642337
996 ‎‡2 ISNI|000000048339389X
996 ‎‡2 ISNI|0000000384216265
996 ‎‡2 BIBSYS|7022446
996 ‎‡2 CYT|AC000257044
996 ‎‡2 CYT|AC000642338
996 ‎‡2 LC|n 2007053385
996 ‎‡2 CYT|AC000653078
996 ‎‡2 NTA|328850780
996 ‎‡2 DNB|1268215465
996 ‎‡2 DNB|1175565555
996 ‎‡2 LC|no2013055685
996 ‎‡2 LC|no2023062528
996 ‎‡2 DNB|1102923168
996 ‎‡2 NII|DA0796033X
996 ‎‡2 DNB|1180082656
996 ‎‡2 PLWABN|9812080183605606
996 ‎‡2 DNB|1265580545
996 ‎‡2 ISNI|000000044461061X
996 ‎‡2 DNB|1060561883
996 ‎‡2 CYT|AC000256730
996 ‎‡2 CYT|AC000639194
996 ‎‡2 CYT|AC000256732
996 ‎‡2 DNB|121245488X
996 ‎‡2 DNB|1287295673
996 ‎‡2 CYT|AC000642440
996 ‎‡2 DNB|1257337505
996 ‎‡2 DNB|1322572178
996 ‎‡2 DNB|1204669848
996 ‎‡2 LC|no2012001371
996 ‎‡2 BNF|15864753
996 ‎‡2 LC|n 82055164
996 ‎‡2 SUDOC|257094245
996 ‎‡2 DNB|1189700204
996 ‎‡2 BIBSYS|90534399
996 ‎‡2 NKC|xx0317119
996 ‎‡2 CYT|AC000633075
996 ‎‡2 LC|no2008008108
996 ‎‡2 ISNI|0000000104032681
996 ‎‡2 SUDOC|133002381
996 ‎‡2 DNB|1189770229
996 ‎‡2 ISNI|0000000491666915
996 ‎‡2 NYNYRILM|170936
996 ‎‡2 ISNI|0000000459621813
996 ‎‡2 LC|no2007051746
996 ‎‡2 DNB|1111067031
996 ‎‡2 LC|n 2017037712
996 ‎‡2 SUDOC|165436182
996 ‎‡2 SUDOC|143415417
996 ‎‡2 BIBSYS|14036656
996 ‎‡2 ISNI|0000000084089380
996 ‎‡2 DNB|1182054447
996 ‎‡2 DNB|1348642912
996 ‎‡2 NTA|145795233
996 ‎‡2 LC|n 2014018407
996 ‎‡2 NTA|231588917
996 ‎‡2 DNB|1160089396
996 ‎‡2 LC|no2021027098
996 ‎‡2 ISNI|0000000050442123
996 ‎‡2 ISNI|0000000492006425
996 ‎‡2 NII|DA12009873
996 ‎‡2 BIBSYS|90285297
996 ‎‡2 BNF|17178637
996 ‎‡2 DNB|1171250789
996 ‎‡2 PLWABN|9810543664705606
996 ‎‡2 ISNI|0000000503860097
996 ‎‡2 CYT|AC000087325
996 ‎‡2 CYT|AC000642347
996 ‎‡2 BIBSYS|90272639
996 ‎‡2 CYT|AC000641659
996 ‎‡2 ISNI|0000000025660639
996 ‎‡2 CYT|AC000653353
996 ‎‡2 ISNI|0000000499496746
996 ‎‡2 DNB|119119099
996 ‎‡2 LC|n 2014071903
996 ‎‡2 ISNI|0000000081242589
996 ‎‡2 DNB|131127751X
996 ‎‡2 ISNI|0000000077028985
996 ‎‡2 ISNI|0000000053900919
996 ‎‡2 DNB|1231716932
996 ‎‡2 DNB|1149082801
996 ‎‡2 CYT|AC000208945
996 ‎‡2 CYT|AC000217845
996 ‎‡2 DNB|140390340
996 ‎‡2 ISNI|0000000508416155
996 ‎‡2 ISNI|0000000443591760
996 ‎‡2 ISNI|0000000500228192
996 ‎‡2 ISNI|0000000483393873
996 ‎‡2 DNB|1324328371
996 ‎‡2 RERO|A000174898
996 ‎‡2 DNB|119523936X
996 ‎‡2 CYT|AC000570089
996 ‎‡2 NUKAT|n 2022077840
996 ‎‡2 ISNI|0000000066887872
996 ‎‡2 SUDOC|228234808
996 ‎‡2 PLWABN|9814295468405606
996 ‎‡2 CYT|AC000208093
996 ‎‡2 DNB|1150544546
996 ‎‡2 ISNI|0000000083993677
996 ‎‡2 BNF|12504926
996 ‎‡2 J9U|987012679272405171
996 ‎‡2 CYT|AC000641822
996 ‎‡2 NSK|000680352
996 ‎‡2 LC|no2015077162
996 ‎‡2 LC|n 2021013626
996 ‎‡2 DNB|1214448445
996 ‎‡2 NII|DA14565572
996 ‎‡2 SUDOC|255127790
996 ‎‡2 LC|no2010024593
996 ‎‡2 DNB|1166602117
996 ‎‡2 DNB|1230838678
996 ‎‡2 NUKAT|n 2013152226
996 ‎‡2 BNF|17048159
996 ‎‡2 CYT|AC000610666
996 ‎‡2 NTA|371224837
996 ‎‡2 ISNI|000000039694223X
996 ‎‡2 ISNI|0000000460101516
996 ‎‡2 SUDOC|230643493
996 ‎‡2 BIBSYS|15006885
996 ‎‡2 LC|no2020043009
996 ‎‡2 DNB|1309774463
996 ‎‡2 BIBSYS|90340730
996 ‎‡2 CYT|AC000661865
996 ‎‡2 ISNI|0000000075348061
996 ‎‡2 ISNI|0000000508935203
996 ‎‡2 LC|no2019059001
996 ‎‡2 DNB|126914586X
996 ‎‡2 LC|no2023023814
996 ‎‡2 NSK|000638817
996 ‎‡2 ISNI|0000000029877878
996 ‎‡2 J9U|987007447696105171
996 ‎‡2 CYT|AC000488326
996 ‎‡2 CYT|AC000641427
996 ‎‡2 J9U|987007308372605171
996 ‎‡2 DNB|1310450463
996 ‎‡2 SUDOC|160985099
996 ‎‡2 LC|no2005099236
996 ‎‡2 DNB|136826598
996 ‎‡2 LC|n 85259209
996 ‎‡2 DNB|142261289
996 ‎‡2 CYT|AC000642831
996 ‎‡2 DNB|1271987716
996 ‎‡2 ISNI|0000000468345849
996 ‎‡2 DNB|136825648
996 ‎‡2 CAOONL|ncf10361991
996 ‎‡2 DNB|126325764X
996 ‎‡2 BNF|17151185
996 ‎‡2 DNB|1196886326
996 ‎‡2 NSK|000750022
996 ‎‡2 DNB|1155265394
996 ‎‡2 ISNI|0000000476883436
996 ‎‡2 DNB|108913651X
996 ‎‡2 DNB|140374302
996 ‎‡2 BIBSYS|3022295
996 ‎‡2 CYT|AC000654480
996 ‎‡2 BNF|17873669
996 ‎‡2 DNB|136826466
996 ‎‡2 BIBSYS|15042050
996 ‎‡2 CYT|AC000257040
996 ‎‡2 DNB|1274460042
996 ‎‡2 CYT|AC000257042
996 ‎‡2 CYT|AC000257043
996 ‎‡2 LC|no2017053426
996 ‎‡2 CYT|AC000257045
996 ‎‡2 DNB|1202538452
996 ‎‡2 PLWABN|9810682296005606
996 ‎‡2 BNF|15615531
996 ‎‡2 DNB|132548279X
996 ‎‡2 NSK|000707971
996 ‎‡2 LC|n 2010001098
996 ‎‡2 CYT|AC000656217
996 ‎‡2 DNB|171460448
996 ‎‡2 DNB|1287690343
996 ‎‡2 KRNLK|KAC201000349
996 ‎‡2 ISNI|0000000038275625
996 ‎‡2 DNB|138456895
996 ‎‡2 SUDOC|177943270
996 ‎‡2 LC|no2020042978
996 ‎‡2 DNB|1267418834
996 ‎‡2 DNB|1020037881
996 ‎‡2 NTA|364176717
996 ‎‡2 PLWABN|9811718348805606
996 ‎‡2 LC|n 81018395
996 ‎‡2 ISNI|0000000493980334
996 ‎‡2 LC|n 2013008346
996 ‎‡2 ISNI|0000000076474780
996 ‎‡2 DNB|1214308538
996 ‎‡2 LC|no2017054752
996 ‎‡2 LC|n 2018011910
996 ‎‡2 ISNI|0000000121380741
996 ‎‡2 NTA|156412543
996 ‎‡2 LC|no2018022424
996 ‎‡2 CYT|AC000256731
996 ‎‡2 NUKAT|n 2013063936
996 ‎‡2 CYT|AC000207214
996 ‎‡2 DNB|1029985944
996 ‎‡2 NDL|00534345
996 ‎‡2 ISNI|0000000450485122
996 ‎‡2 LC|no2010071473
996 ‎‡2 SUDOC|262210851
996 ‎‡2 ISNI|0000000468279562
996 ‎‡2 LC|n 89111272
996 ‎‡2 LC|no2022066869
996 ‎‡2 DNB|1315026449
996 ‎‡2 NUKAT|n 2018240166
996 ‎‡2 DNB|1106403495
996 ‎‡2 SUDOC|188817654
996 ‎‡2 LC|n 99043685
996 ‎‡2 DNB|1208403656
996 ‎‡2 CYT|AC000641595
996 ‎‡2 CYT|AC000653626
996 ‎‡2 BIBSYS|14036638
996 ‎‡2 CAOONL|ncf10188565
996 ‎‡2 LC|no2020043133
996 ‎‡2 J9U|987007347175405171
996 ‎‡2 ISNI|0000000431354290
996 ‎‡2 BNF|18042726
996 ‎‡2 NSK|000555269
996 ‎‡2 ISNI|0000000036558023
996 ‎‡2 LC|n 2004055334
996 ‎‡2 CYT|AC000642035
996 ‎‡2 LC|no2015081298
996 ‎‡2 LC|n 2005033496
996 ‎‡2 DNB|1178565599
996 ‎‡2 DNB|1202857736
996 ‎‡2 DNB|138352437
996 ‎‡2 LC|no2023077710
996 ‎‡2 DNB|1161467408
996 ‎‡2 DNB|132471123X
996 ‎‡2 ISNI|0000000124283197
996 ‎‡2 DNB|1149977329
996 ‎‡2 CYT|AC000256054
996 ‎‡2 CYT|AC000639321
996 ‎‡2 DNB|122031241X
996 ‎‡2 NUKAT|n 2011112672
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏